StockData
OPKO Health, Inc. logo

OPKO Health, Inc. (OPK) stock

OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.62+0.00 (0.00%)

Close on Nov 17, 2026Market cap $1.21BP/E –Yield –

OPKO Health pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

OPKO Health's pe ratio was 28.5× on Jan 31, 2022, against 52.3× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jan 31, 202228.5×−15.3
2021Dec 31, 202143.7×−8.6
2016Oct 31, 201652.3×–

More OPKO Health figures

See a number that looks wrong?